Close

Publications

WEERASURIYA, CK; CLARK, RA; WHITE, RG; Harris, RC;
2020
Journal of internal medicine, (2020).288 6 10.1111/joim.13197.
Russell, FM; GREENWOOD, B;
2020
HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2020).17 5 10.1080/21645515.2020.1827882.
Toh, ZQ; He, L; Chen, C; Huang, A; Russell, FM; Garland, SM; Reyburn, R; Ratu, T; Tuivaga, E; Frazer, IH; MULHOLLAND, EK; Licciardi, PV;
2020
FRONTIERS IN IMMUNOLOGY, (2020).11, 10.3389/fimmu.2020.585768.
Estimating the value-based price of new tuberculosis vaccines in India and China.
WEERASURIYA, C; Harris, R; MCQUAID, C; BOZZANI, F; Gomez, GB; WHITE, R;
2020
(2020).
Do evaluations of Tuberculosis Active Case Finding report estimates of resource need? A review of the evidence.
Clarkson, MC; MCQUAID, CF; HOUBEN, RM; Menzies, N; SWEENEY, S; KRANZER, K; WHITE, RG;
2020
(2020).
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on rifampicin resistant and multidrug resistant tuberculosis in India and China.
WEERASURIYA, C; Harris, R; MCQUAID, C; BOZZANI, F; Gomez, GB; WHITE, R;
2020
(2020).
Lazarus, JV; Ratzan, SC; Palayew, A; Gostin, LO; LARSON, HJ; Rabin, K; Kimball, S; El-Mohandes, A;
2020
NATURE MEDICINE, (2020).27, 10.1038/s41591-020-1124-9.
KITONSA, J; Ggayi, A-B; ANYWAINE, Z; Kisaakye, E; Nsangi, L; Basajja, V; NYANTARO, M; WATSON-JONES, D; Shukarev, G; Ilsbroux, I; Robinson, C; KALEEBU, P;
2020
GLOBAL HEALTH ACTION, (2020).13 1 10.1080/16549716.2020.1829829.